Title of article :
The Relationship between Matrix Metalloproteinase Gene Polymorphisms and Tumor Type, Tumor Size, and Metastasis in Women with Breast Cancer in Central Iran
Author/Authors :
Hamid Mohammad نويسنده Molecular Medicine Division, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran , Dehghan Manshadi Zahra نويسنده Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , Kosari Farid نويسنده Pathology Laboratory, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran , Tayebinia Heidar نويسنده Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , Khodadadi Iraj نويسنده Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract :
Background: Matrix metalloproteinases-2 and -9 play important roles in the
development of breast cancer by hydrolyzing the extracellular matrix. Since ?1306C/T
and ?1562C/T polymorphisms are located at the promoter regions of the matrix metalloproteinase-
2 and -9 genes, respectively, C to T substitution may affect promoter
activity and impact the rate of extracellular matrix degradation and cancerous cell
proliferation. Therefore, we aimed to determine the genotype and allele frequencies of
these polymorphisms in Iranian healthy women and women with breast cancer. We have
also examined the correlation of genotypes with clinicopathological parameters such
as tumor type, tumor size, and metastasis to lymph nodes.
Methods: This case-control study enrolled 200 women with breast cancer and 200
age-matched healthy women. DNA was extracted, and we determined the genotype
and allele frequencies of ?1306C/T matrix metalloproteinase-2 and ?1562C/T matrix
metalloproteinase-9 polymorphisms by the polymerase chain reaction-restriction
fragment length polymorphism method. Additionally, tumor size ( < 20 mm/ > 20 mm),
tumor type (ductal/non-ductal), and metastasis (yes/no) were determined.
Results: Genotype and allele frequencies of the ?1306C/T matrix metalloproteinase-
2 polymorphism showed no significant association with the occurrence of
breast cancer. Genotype and allele distribution differed in the ?1562C/T matrix metalloproteinase-
9 polymorphism and indicated a 4.83-fold increase in the risk of breast
cancer for T allele carriers. There was no likelihood of any interaction found between
the two polymorphisms and susceptibility to breast cancer. In addition, the ?1562C/T
matrix metalloproteinase-9 T allele showed an association with metastasis to lymph
nodes but we observed no association between the ?1306C/T matrix metalloproteinase-
2 polymorphism and clinicopathological features.
Conclusion: The ?1562C/T matrix metalloproteinase-9 polymorphism is involved
in the pathogenesis of breast cancer in Iranian women. The T allele may increase the
risk of disease.